Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biotricity Inc. (BTCY) had Revenue of $13.79M for the most recently reported fiscal year, ending 2025-03-31.

Quarterly Annual

Figures for fiscal year ending 2025-03-31

Income Statement Financials
Revenue	$13.79M
Net Income	$-11.94M
Cost of Goods Sold	$3.23M
Gross Profit	$10.56M
Operating Expenses	$16.24M
Operating Income	$-2.45M
Non-Operating Income/Expense	$-5.97M
Pre-Tax Income	$-8.42M
Normalized Pre-Tax Income	$-8.42M
Income after Taxes	$-8.42M
Income from Continuous Operations	$-8.42M
Consolidated Net Income/Loss	$-8.42M
Normalized Income after Taxes	$-8.42M
EBIT	$-2.45M
EBITDA	$-0.50M
Weighted-Average Shares Outstanding (Basic)	21.52M
Weighted-Average Shares Outstanding (Diluted)	21.52M
Earnings per Share (EPS) (Basic)	$-0.56
Earnings per Share (EPS) (Diluted)	$-0.56
Balance Sheet Financials
Current Assets	$4.64M
Property, Plant, and Equipment	$0.01M
Long-Term Assets	$1.00M
Total Assets	$5.64M
Current Liabilities	$20.64M
Long-Term Debt	$13.14M
Long-Term Liabilities	$17.02M
Total Liabilities	$37.66M
Common Equity	$-32.01M
Tangible Shareholders Equity	$-32.01M
Shareholders Equity	$-32.01M
Common Shares Outstanding	26.08M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.38M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$1.93M
Beginning Cash	$0.79M
End Cash	$0.37M
Increase/Decrease in Cash	$-0.42M
Stock-Based Compensation	$1.78M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	$-0.03M
Fundamental Metrics & Ratios
Current Ratio	0.22
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.70
Debt to Equity Ratio	-0.79
Gross Margin	76.61%
Operating Margin	-17.76%
EBIT Margin	-17.76%
EBITDA Margin	-3.65%
Pre-Tax Profit Margin	-61.07%
Profit Margin	-86.60%
Free Cash Flow	$-2.38M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	2.44
Inventory Turnover	2.07
Receiveable Turnover	8.31
Days Sales in Receivables	43.90
Return on Equity	26.30%
Return on Tangible Equity	26.30%
Return on Assets	-149.29%
Return on Investments	44.62%
Book Value Per Share	$-1.23
Free Cash Flow per Share	$-0.11
Operating Cash Flow per Share	$-0.11

Data from Zacks Investment Research, Inc.